CaliforniaLifeScience.com is a resource for the life science industry in the state of California.
Search
 
 

About
 Board
 Members Only
 Group Purchasing
 Calendar
Industry
 Directory
 CA BioHistory (TM)
 Economic Develop.
 Facilities
 Technology Transfer
Career
 Destination CA
 Job Search
 Post a Job
 Submit Resume
News
 Local CA News
 Submit News Release
 Calendar
 Submit Event
 CEO Reading
Patient
 Clinical Trials
 Local Support
 National Resources
Education
 K-12
 Higher Ed
 BioEd Reading
Advertising
Feedback
Site Map
Print Page
Home

Community Service Ad: Every Child Deserves a Chance to Play Baseball

Survey

Should regulation of direct to consumer genetic testing be increased?

  Yes   No

Please tell us what you think:
 

Survey Results

BioFact:

(1895) - A German company, Hochst am Main, sells Nitragin, the first commercially cultured Rhizobia isolated from root nodules.

 
HDMA’s Looking Forward in Reverse Logistics Healthcare Seminar - Sept. 22-23 - Dallas, TX


Opinion Poll: Is the SBIR venture capital restriction on ownership hurting your company?

Poll Results (June, 2006)

Yes: 78% (31)
No: 22% (9)

Select Comments

  • It restricts us in raising additional capital to fund new product research and early stage development. This has slowed our growth and limits our ability in generating innovative and inventive products.

  • No...and should be that way. VC funding implies a path to revenues.

  • This should be open to all small business and start ups, preclinical companies.

Back to Opinion Poll


            

© 2008 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

CaliforniaLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of California.